IKS03, a Next Generation CD19-Targeted Antibody Drug Conjugate, Shows Potent Activity in Preclinical Models of Aggressive B-Cell Lymphomas

IKS03, a Next Generation CD19-Targeted Antibody Drug Conjugate, Shows Potent Activity in Preclinical Models of Aggressive B-Cell Lymphomas

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.3134-3135
Hauptverfasser: Deckert, Jutta, Thirlway, Jenny, Mysliwy, Justyna, Lodge, Adam, Park, Yun-Hee, Ryu, Hyun-Min, Han, Na Ra, Song, Ho Young, Chung, Chul-Woong, Lutz, Robert J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3135
container_issue Supplement 1
container_start_page 3134
container_title Blood
container_volume 140
creator Deckert, Jutta
Thirlway, Jenny
Mysliwy, Justyna
Lodge, Adam
Park, Yun-Hee
Ryu, Hyun-Min
Han, Na Ra
Song, Ho Young
Chung, Chul-Woong
Lutz, Robert J
description
doi_str_mv 10.1182/blood-2022-158983
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_158983</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122029056</els_id><sourcerecordid>S0006497122029056</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1853-71c7df8ad947d968a0291202f1db93f3713dbfd4a6b04460ee344685317924c43</originalsourceid><addsrcrecordid>eNp9kEtOwzAURS0EEuWzAGZvARj8SZtEjEr4igKVWsaRY78EV2lc2abQLbBqUsqY0R2dK51DyBlnF5xn4rJqnTNUMCEoH2Z5JvfIgA9FRhkTbJ8MGGMjmuQpPyRHISwY44kUwwH5fnyaMXkOCl7wK8I9duhVtK6D4obndK58gxENjLtoK2c2cOM_Gihct_hoVMRzmL27zwBTF7GLMNbRrm3cgO1g6lG3trNatfDsDLYBXA3jpvEYgl0jXNMC2xYmm-Xq3S1VOCEHtWoDnv7tMXm7u50XD3Tyev9YjCdU82woacp1aupMmTxJTT7KFBM578Vrbqpc1jLl0lS1SdSoYkkyYoiyn57kaS4Snchjwne_2rsQPNblytul8puSs3Ibs_yNWW5jlruYPXO1Y3oNXFv0ZdAWO43G9pqxNM7-Q_8AhaZ8Hw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>IKS03, a Next Generation CD19-Targeted Antibody Drug Conjugate, Shows Potent Activity in Preclinical Models of Aggressive B-Cell Lymphomas</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Deckert, Jutta ; Thirlway, Jenny ; Mysliwy, Justyna ; Lodge, Adam ; Park, Yun-Hee ; Ryu, Hyun-Min ; Han, Na Ra ; Song, Ho Young ; Chung, Chul-Woong ; Lutz, Robert J</creator><creatorcontrib>Deckert, Jutta ; Thirlway, Jenny ; Mysliwy, Justyna ; Lodge, Adam ; Park, Yun-Hee ; Ryu, Hyun-Min ; Han, Na Ra ; Song, Ho Young ; Chung, Chul-Woong ; Lutz, Robert J</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-158983</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.3134-3135</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1853-71c7df8ad947d968a0291202f1db93f3713dbfd4a6b04460ee344685317924c43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Deckert, Jutta</creatorcontrib><creatorcontrib>Thirlway, Jenny</creatorcontrib><creatorcontrib>Mysliwy, Justyna</creatorcontrib><creatorcontrib>Lodge, Adam</creatorcontrib><creatorcontrib>Park, Yun-Hee</creatorcontrib><creatorcontrib>Ryu, Hyun-Min</creatorcontrib><creatorcontrib>Han, Na Ra</creatorcontrib><creatorcontrib>Song, Ho Young</creatorcontrib><creatorcontrib>Chung, Chul-Woong</creatorcontrib><creatorcontrib>Lutz, Robert J</creatorcontrib><title>IKS03, a Next Generation CD19-Targeted Antibody Drug Conjugate, Shows Potent Activity in Preclinical Models of Aggressive B-Cell Lymphomas</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kEtOwzAURS0EEuWzAGZvARj8SZtEjEr4igKVWsaRY78EV2lc2abQLbBqUsqY0R2dK51DyBlnF5xn4rJqnTNUMCEoH2Z5JvfIgA9FRhkTbJ8MGGMjmuQpPyRHISwY44kUwwH5fnyaMXkOCl7wK8I9duhVtK6D4obndK58gxENjLtoK2c2cOM_Gihct_hoVMRzmL27zwBTF7GLMNbRrm3cgO1g6lG3trNatfDsDLYBXA3jpvEYgl0jXNMC2xYmm-Xq3S1VOCEHtWoDnv7tMXm7u50XD3Tyev9YjCdU82woacp1aupMmTxJTT7KFBM578Vrbqpc1jLl0lS1SdSoYkkyYoiyn57kaS4Snchjwne_2rsQPNblytul8puSs3Ibs_yNWW5jlruYPXO1Y3oNXFv0ZdAWO43G9pqxNM7-Q_8AhaZ8Hw</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Deckert, Jutta</creator><creator>Thirlway, Jenny</creator><creator>Mysliwy, Justyna</creator><creator>Lodge, Adam</creator><creator>Park, Yun-Hee</creator><creator>Ryu, Hyun-Min</creator><creator>Han, Na Ra</creator><creator>Song, Ho Young</creator><creator>Chung, Chul-Woong</creator><creator>Lutz, Robert J</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>IKS03, a Next Generation CD19-Targeted Antibody Drug Conjugate, Shows Potent Activity in Preclinical Models of Aggressive B-Cell Lymphomas</title><author>Deckert, Jutta ; Thirlway, Jenny ; Mysliwy, Justyna ; Lodge, Adam ; Park, Yun-Hee ; Ryu, Hyun-Min ; Han, Na Ra ; Song, Ho Young ; Chung, Chul-Woong ; Lutz, Robert J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1853-71c7df8ad947d968a0291202f1db93f3713dbfd4a6b04460ee344685317924c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deckert, Jutta</creatorcontrib><creatorcontrib>Thirlway, Jenny</creatorcontrib><creatorcontrib>Mysliwy, Justyna</creatorcontrib><creatorcontrib>Lodge, Adam</creatorcontrib><creatorcontrib>Park, Yun-Hee</creatorcontrib><creatorcontrib>Ryu, Hyun-Min</creatorcontrib><creatorcontrib>Han, Na Ra</creatorcontrib><creatorcontrib>Song, Ho Young</creatorcontrib><creatorcontrib>Chung, Chul-Woong</creatorcontrib><creatorcontrib>Lutz, Robert J</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deckert, Jutta</au><au>Thirlway, Jenny</au><au>Mysliwy, Justyna</au><au>Lodge, Adam</au><au>Park, Yun-Hee</au><au>Ryu, Hyun-Min</au><au>Han, Na Ra</au><au>Song, Ho Young</au><au>Chung, Chul-Woong</au><au>Lutz, Robert J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IKS03, a Next Generation CD19-Targeted Antibody Drug Conjugate, Shows Potent Activity in Preclinical Models of Aggressive B-Cell Lymphomas</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>3134</spage><epage>3135</epage><pages>3134-3135</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-158983</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.3134-3135
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_158983
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title IKS03, a Next Generation CD19-Targeted Antibody Drug Conjugate, Shows Potent Activity in Preclinical Models of Aggressive B-Cell Lymphomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T03%3A50%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IKS03,%20a%20Next%20Generation%20CD19-Targeted%20Antibody%20Drug%20Conjugate,%20Shows%20Potent%20Activity%20in%20Preclinical%20Models%20of%20Aggressive%20B-Cell%20Lymphomas&rft.jtitle=Blood&rft.au=Deckert,%20Jutta&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=3134&rft.epage=3135&rft.pages=3134-3135&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-158983&rft_dat=%3Celsevier_cross%3ES0006497122029056%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122029056&rfr_iscdi=true